Anita S.
- Country
- Italy
- Department
- Oncoematologo pediatrico
Research Overview
- Evaluation of Dexamethasone Versus Prednisone in Induction Therapy for Pediatric and Adolescent Lymphoblastic Lymphoma: A Randomized Controlled Trial
- Phase 3 Study of Busulfan, Melphalan, and Chemoimmunotherapy in High-Risk Neuroblastoma Patients with Insufficient Metastatic Response
- Evaluation of Irinotecan, Ifosfamide, Vincristine, and Dactinomycin in Frontline and Relapsed Rhabdomyosarcoma in Pediatric and Adult Populations
Data & Insights
Has run more than one trial at 154 of 291 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating aggressive childhood cancers, with particular focus on rhabdomyosarcoma and high-risk neuroblastoma management strategies.
- Advanced Sarcoma Treatment
- Neuroblastoma Therapy Protocols
- Multi-modal Cancer Treatment
Their expertise extends to integrating various therapeutic approaches for optimal patient outcomes.
Therapeutic Innovation
The investigator focuses on developing enhanced treatment protocols incorporating chemotherapy combinations and targeted therapies for pediatric solid tumors.
- Novel Drug Combinations
- Systemic Therapy Optimization
- Risk-Adapted Treatment Strategies
Their work encompasses evaluating innovative therapeutic approaches for both newly diagnosed and relapsed cases.
Radiation Oncology
The investigator explores optimization of radiotherapy timing and dose escalation strategies in pediatric cancer treatment protocols.
- Pre-operative Radiotherapy
- Post-operative Radiation
- Targeted Radiation Approaches
Their expertise includes determining optimal radiation delivery sequences for complex pediatric cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.